Impact of O6-methylguanine-DNA Methyltransferase (MGMT) Promoter Methylation and MGMT Expression on Dacarbazine Treated Sarcoma Patients (MGMT)
Clinical trial NCT04893356 · UNKNOWN
Trial details
- NCT number
- NCT04893356
- Sponsor
- National Cancer Institute, Naples
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-01-20
- Primary completion
- 2022-02-28
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.